Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.
New research reveals these medications impact everything from heart health to restaurant menus.
Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...
Verywell Health on MSN

Medications for type 2 diabetes

Medically reviewed by Jane Kim, MD Key Takeaways Metformin is the first choice medicine for type 2 diabetes. Meglitinides can ...